» Articles » PMID: 33124951

Prognostic and Clinical Significance of Long Non-coding RNA SNHG12 Expression in Various Cancers

Overview
Journal Bioengineered
Date 2020 Oct 30
PMID 33124951
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, increasing studies suggested that lncRNA SNHG12 was aberrantly expressed in kinds of cancers. However, definite prognostic value of SNHG12 remains unclear. We conducted this meta-analysis to evaluate the association between SNHG12 expression level and cancer prognosis. A literature retrieval was conducted by searching kinds of databases. The meta-analysis was performed by using Revman 5.2 and Stata 12.0 software. Besides, The Cancer Genome Atlas dataset was analyzed to validate the results in our meta-analysis via using Gene Expression Profiling Interactive Analysis. The pooled results showed that high SNHG12 expression significantly indicated worse overall survival and recurrence-free survival. Tumor type, sample size, survival analysis method, and cutoff value did not alter SNHG12 prognosis value according to stratified analysis results. Additionally, higher expression of SNHG12 suggested unfavorable clinicopathological outcomes including larger tumor size, lymph node metastasis, distant metastasis, and advanced clinical stage. Online cross-validation in TCGA dataset further indicated that cancer patients with upregulated SNHG12 expression had worse overall survival and disease-free survival. Therefore, elevated SNHG12 expression was associated with poor survival and unfavorable clinical outcomes in various cancers, and therefore might be a potential prognostic biomarker in human cancers. Akt: protein kinase B; CESC: cervical squamous cell carcinoma and endocervical adenocarcinoma; ceRNA: competitive endogenous RNA; CNKI: China National Knowledge Infrastructure; CI: confidence interval; CCNE1: cyclin E1; COAD: colon adenocarcinoma; DM: distant metastasis; DFS: disease-free survival; EMT: epithelial-mesenchymal transition; FISH: fluorescence in situ hybridization; FIGO: the International Federation of Gynecology and Obstetrics; GEPIA: Gene Expression Profiling Interactive Analysis; HR: hazard ratio; HIFα: hypoxia-inducible factor 1 α; KIRC: kidney renal clear cell carcinoma; KIRP: kidney renal papillary cell carcinoma; LIHC: hepatocellular carcinoma; LNM: lymph node metastasis; mTOR: mechanistic target of rapamycin kinase; MMP-9: matrix metalloproteinase 9; MCL1: myeloid cell leukemia 1; MLK3: mixed-lineage protein kinase 3; N/A: not available; NOS: Newcastle-Ottawa Scale; OR: odd ratio; OS: overall survival; PSA: prostate-specific antigen; PI3K: phosphoinositide 3-kinase; qRT-PCR: quantitative real-time polymerase chain reaction; READ: rectum adenocarcinoma; RFS: recurrence-free survival; SARC: sarcoma; SNHG12: small nucleolar RNA host gene 12; STAT3: signal transducer and activator of transcription 3; SOX4: SRY-box transcription factor 4; SOX5: SRY-box transcription factor 5; STAD: stomach adenocarcinoma; TCGA: The Cancer Genome Atlas; TNM: tumor node metastasis; WWP1: WW domain-containing E3 ubiquitin protein ligase 1; WHO grade: World Health Organization grade; ZEB2: zinc finger E-box-binding homeobox 2.

Citing Articles

Clinical significance and underlying mechanism of long non-coding RNA SNHG12 in lower extremity deep venous thrombosis.

Xiao S, Wang C, Li Y, Zhang K, Jiao X, Zhao Z Clin Transl Sci. 2024; 17(10):e70023.

PMID: 39396235 PMC: 11471149. DOI: 10.1111/cts.70023.


Non-coding transcriptome profiles in clear-cell renal cell carcinoma.

Tesarova T, Fiala O, Hora M, Vaclavikova R Nat Rev Urol. 2024; 22(3):151-174.

PMID: 39242964 DOI: 10.1038/s41585-024-00926-3.


lncRNAs are potential prognostic markers in patients with nasopharyngeal carcinoma in China: A systematic review and meta‑analysis.

Yu P, Ye J, Zhao S, Cai Y Mol Clin Oncol. 2024; 20(2):11.

PMID: 38213659 PMC: 10777463. DOI: 10.3892/mco.2023.2709.


Roles of long noncoding RNA in triple-negative breast cancer.

Das P, Siddika A, Rashel K, Auwal A, Soha K, Rahman M Cancer Med. 2023; 12(20):20365-20379.

PMID: 37795578 PMC: 10652353. DOI: 10.1002/cam4.6600.


A high level of the long non-coding RNA is associated with poor prognosis in breast cancer and activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis.

She Q, Chen Y, Liu H, Tan J, Li Y Bioengineered. 2023; 13(5):13437-13451.

PMID: 36700469 PMC: 9276029. DOI: 10.1080/21655979.2022.2074108.


References
1.
Jin X, Chen X, Zhang Z, Hu W, Ou R, Li S . Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis. J Cell Physiol. 2018; 234(5):6624-6632. DOI: 10.1002/jcp.27403. View

2.
Serrati S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S . Next-generation sequencing: advances and applications in cancer diagnosis. Onco Targets Ther. 2016; 9:7355-7365. PMC: 5144906. DOI: 10.2147/OTT.S99807. View

3.
Yuan J, Yang F, Wang F, Ma J, Guo Y, Tao Q . A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25(5):666-81. DOI: 10.1016/j.ccr.2014.03.010. View

4.
Li X, Meng X, Wei C, Zhou Y, Chen H, Huang H . Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq. Mol Cancer Res. 2018; 16(12):1879-1888. DOI: 10.1158/1541-7786.MCR-17-0776. View

5.
Zhang Y, Lun L, Li H, Wang Q, Lin J, Tian R . The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis. Sci Rep. 2017; 7(1):13080. PMC: 5638961. DOI: 10.1038/s41598-017-10001-0. View